By Peter Nurse Investing.com - European stock markets traded higher Friday, seeking to end a volatile week on a positive note as investors wait for more news about the omicron...
“Mad Money” host Jim Cramer rings the lightning round bell on Vir Biotechnology, Enbridge, On Semiconductor and Robinhood.
By Ludwig Burger (Reuters) -Laboratory analysis of the antibody-based COVID-19 therapy GlaxoSmithKline (NYSE:GSK) is developing with U.S. partner Vir has indicated the drug is...
Pfizer Jab & GSK's Antibody Drug Are Effective Against OmicronAfter teasing various aspects of his plan to protect Americans from the omciron variant (which is arriving at the...
Stock index futures are mixed ahead of the open while investors try to digest yesterday’s selloff. Heavy selling into the close is often seen as a bad sign for stocks, so...
Yesterday, we pointed out that based on fundamentals, gold should have weakened after the Federal Reserve Chairman, Jerome Powell, made a clear, strong case for tightening monetary...
GlaxoSmithKline plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceuticals R&D, Vaccines, and Consumer Healthcare. The company offers pharmaceutical products comprising medicines in the therapeutic areas, such as respiratory, HIV, immuno-inflammation, oncology, anti-viral, central nervous system, cardiovascular and urogenital, metabolic, anti-bacterial, and dermatology. It also provides consumer healthcare products in wellness, oral health, nutrition, and skin health categories. The company offers its consumer healthcare products in the form of nasal sprays, tablets, syrups, lozenges, gum and trans-dermal patches, caplets, infant syrup drops, liquid filled suspension, wipes, gels, effervescents, toothpastes, toothbrushes, mouthwashes, denture adhesives and cleansers, topical creams and non-medicated patches, lip balm, gummies, and soft chews. It has collaboration agreements with 23andMe; Lyell Immunopharma, Inc.; Novartis; Sanofi SA; Surface Oncology; Progentec Diagnostics, Inc.; Alector, Inc.; and CureVac AG., as well as strategic partnership with IDEAYA Biosciences, Inc. and Vir Biotechnology, Inc. GlaxoSmithKline plc was founded in 1715 and is headquartered in Brentford, the United Kingdom.
Type | 5 Min | 15 Min | Hourly | Daily | Monthly |
|---|---|---|---|---|---|
| Moving Averages | Strong Sell | Sell | Strong Sell | Neutral | Strong Buy |
| Technical Indicators | Strong Buy | Neutral | Strong Sell | Strong Sell | Strong Buy |
| Summary | Strong Sell | Neutral | Strong Sell | Sell | Strong Buy |
Name | Last | High | Low | Chg. | Chg. % | Vol. | Time | ||
|---|---|---|---|---|---|---|---|---|---|
| 161.84 | 164.96 | 159.72 | -1.92 | -1.17% | 117.63M | NASDAQ | |||
| 3.75 | 3.95 | 3.60 | -0.22 | -5.54% | 3.38M | NASDAQ | |||
| 32.07 | 32.51 | 31.92 | -0.29 | -0.90% | 320.29K | NYSE | |||
| 2,840.00 | 2,888.00 | 2,806.00 | -19.3 | -0.67% | 1.96M | NASDAQ | |||
| 306.84 | 313.75 | 299.50 | -3.55 | -1.14% | 26.91M | NASDAQ | |||
| 15.10 | 15.46 | 14.93 | -0.23 | -1.50% | 522.11K | NYSE | |||
| 10.85 | 11.09 | 10.62 | -0.20 | -1.81% | 5.36M | NYSE | |||
| 306.93 | 321.29 | 301.30 | -14.33 | -4.46% | 53.55M | NASDAQ | |||
| 3,389.79 | 3,469.86 | 3,338.60 | -47.57 | -1.38% | 3.84M | NASDAQ | |||
| 1.44 | 1.55 | 1.38 | -0.0700 | -4.64% | 13.67M | NYSE | |||
| 54.27 | 54.41 | 53.10 | +1.23 | +2.32% | 37.06M | NYSE | |||
| 18.22 | 18.26 | 17.83 | +0.04 | +0.22% | 21.91M | NYSE | |||
| 5.84 | 5.88 | 5.76 | +0.040 | +0.69% | 12.08M | NYSE | |||
| 0.24 | 0.00 | 0.00 | -0.0040 | -1.64% | 4.53M | NYSE | |||
| 23.58 | 24.83 | 23.43 | -0.57 | -2.36% | 9.98M | NYSE |